A
Arnon Nagler
Researcher at Sheba Medical Center
Publications - 1435
Citations - 51740
Arnon Nagler is an academic researcher from Sheba Medical Center. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 98, co-authored 1316 publications receiving 44298 citations. Previous affiliations of Arnon Nagler include French Institute of Health and Medical Research & University of Paris.
Papers
More filters
Journal ArticleDOI
Outcome of patients with HTLV-1-associated adult T-cell leukemia/lymphoma after SCT: a retrospective study by the EBMT LWP
Ali Bazarbachi,Kate Cwynarski,Ariane Boumendil,Herve Finel,P. Fields,Kavita Raj,Arnon Nagler,M. Mohty,Anna Sureda,Peter Dreger,Olivier Hermine,Olivier Hermine +11 more
TL;DR: Overall these results indicate that allo-SCT but not auto-S CT may salvage a subset of ATL patients, supporting the existence of graft vs ATL effect also in non-Japanese patients.
Journal ArticleDOI
Functional CXCR4-Expressing Microparticles and SDF-1 Correlate with Circulating Acute Myelogenous Leukemia Cells
Alexander Kalinkovich,Sigal Tavor,Sigal Tavor,Abraham Avigdor,Abraham Avigdor,Joy Kahn,Alexander Brill,Isabelle Petit,Polina Goichberg,Melania Tesio,Neta Netzer,Elizabeth Naparstek,Izhar Hardan,Arnon Nagler,Igor B. Resnick,Alexander Tsimanis,Tsvee Lapidot +16 more
TL;DR: The findings suggest that functional CXCR4(+) microparticles and SDF-1 are involved in the progression of AML and it is proposed that their levels are potentially valuable as an additional diagnostic AML variable.
Journal ArticleDOI
External validation and comparison of multiple prognostic scores in allogeneic hematopoietic stem cell transplantation
Roni Shouval,Roni Shouval,Joshua A Fein,Joshua A Fein,Aniela Shouval,Aniela Shouval,Ivetta Danylesko,Ivetta Danylesko,Noga Shem-Tov,Noga Shem-Tov,Maya Zlotnik,Maya Zlotnik,Ronit Yerushalmi,Ronit Yerushalmi,Avichai Shimoni,Avichai Shimoni,Arnon Nagler,Arnon Nagler +17 more
TL;DR: Overall, allo-HSCT prognostic systems may be useful for risk stratification, but individual prediction remains a challenge, as reflected by the scores' limited discriminative capacity.
Journal ArticleDOI
Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD.
Raphael Carapito,Nicolas Jung,Nicolas Jung,Marius Kwemou,Marius Kwemou,Meiggie Untrau,Meiggie Untrau,Sandra Michel,Angélique Pichot,Angélique Pichot,Gaëlle Giacometti,Cécile Macquin,Cécile Macquin,Wassila Ilias,Wassila Ilias,Aurore Morlon,Irina Kotova,Petya Apostolova,Annette Schmitt-Graeff,Anne Cesbron,Katia Gagne,Machteld Oudshoorn,Bronno van der Holt,Myriam Labalette,Eric Spierings,Christophe Picard,Pascale Loiseau,Pascale Loiseau,Ryad Tamouza,Ryad Tamouza,Antoine Toubert,Antoine Toubert,A. Parissiadis,Valérie Dubois,Xavier Lafarge,Myriam Maumy-Bertrand,Frédéric Bertrand,Luca Vago,Fabio Ciceri,Catherine Paillard,Sergi Querol,Jorge Sierra,Katharina Fleischhauer,Arnon Nagler,Myriam Labopin,Hidetoshi Inoko,Hidetoshi Inoko,Peter A. von dem Borne,Jürgen Kuball,Masao Ota,Masao Ota,Yoshihiko Katsuyama,Yoshihiko Katsuyama,Mauricette Michallet,Bruno Lioure,Régis Peffault de Latour,Didier Blaise,Jan J. Cornelissen,Ibrahim Yakoub-Agha,Frans H.J. Claas,Philippe Moreau,Noel Milpied,Dominique Charron,Dominique Charron,Mohamad Mohty,Robert Zeiser,Gérard Socié,Seiamak Bahram +67 more
TL;DR: The tight linkage disequilibrium between MICA and HLA-B renders identifying a MICA-matched donor readily feasible in clinical practice and significantly influences key clinical outcomes of HCT in which a marked reduction of GVHD is paramount.
Journal ArticleDOI
Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study.
Houli Zhao,Jieping Wei,Guoqing Wei,Yi Luo,Jimin Shi,Qu Cui,Zhao Mingfeng,Aibin Liang,Qing Zhang,Jianmin Yang,Xin Li,Jing Chen,Xianmin Song,Hongmei Jing,Yuhua Li,Siguo Hao,Wenjun Wu,Yamin Tan,Jian Yu,Yanmin Zhao,Xiaoyu Lai,Elaine Tan Su Yin,Yunxiong Wei,Ping Li,Jing Huang,Tao Wang,Didier Blaise,Lei Xiao,Alex H. Chang,Arnon Nagler,Mohamad Mohty,He Huang,Yongxian Hu +32 more
TL;DR: Haploidentical hematopoietic stem cell transplantation with pre-transplant MRD negativity after CAR-T therapy could greatly improve LFS and OS in patients with relapsed/refractory acute lymphoblastic leukemia.